While many expected big things from Zoetis (ZTS) — a spinoff of Pfizer’s (PFE) animal health business — it turns out that supplying vets isn’t as good of a business (so far) as supplying pet owners directly.
PetMed Express (PETS) — known by many as 1-800-PETMEDS — is a licensed pharmacy much like Walgreens (WAG) and CVS (CVS) that offers all major brand medications for a cheaper price and delivered to your door. PETS has posted a similar climb to VCA, gaining 53% during the past 52 weeks and more than 33% year-to-date. Meanwhile, Zoetis is down a couple percentage points since its February IPO.
PetMed is slated to enjoy 5% annualized earnings growth over the next five years — which doesn’t sound like much, but is a vast improvement over its decidedly downward trend during the past five years.
Plus, PetMed Express offers investors another treat: a mouth-watering 4.5% dividend. The company began paying a 10-cent dividend in 2009, and has increased it by 70% since then to its current 17-cent payout.